Novel CSF and plasma biomarkers such as oxylipins (oxidized lipid mediators), GPX4 fragments, and 8‐iso‐prostaglandin F2α have been identified as indicators of ferroptosis activity and oxidative lipid damage in stroke patients. Here, GPX4 is linked to Stroke.